Javadin Solution
Product Images NDC 24338-115

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Javadin (NDC 24338-115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Azurity Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle-label (Bottle Label)

This is a description of Javadin' (Clonidine HCI) Oral Solution with a concentration of 0.02 mg/mL. Each mL contains 0.02 mg of clonidine hydrochloride. The recommended dosage should be followed as per the prescribing information. It is advised to keep the medication away from children and store it between 20°C to 25°C (68°F to 77°F). Unused portions should be discarded after 60 days of opening. The product is manufactured for Azurity Pharmaceuticals, Inc. and the lot and expiration dates are also provided.*

FDA Label Image

Carton-label (Carton Label)

This is a medication label for Javadin (clonidine HCI) Oral Solution. Each mL contains 0.02 mg of clonidine hydrochloride. It is manufactured for Azurity Pharmaceuticals, Inc. The recommended dosage should be followed as per prescribing information. The oral solution should be stored at temperatures between 20°C to 25°C (68°F to 77°F). Unused portion should be discarded after 60 days of first opening. It is advisable to use an appropriate oral syringe for dosing.*

FDA Label Image

Clonidine Structure (Clonidine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.